Amit Hazan
Stock Analyst at Goldman Sachs
(2.12)
# 2,824
Out of 4,749 analysts
95
Total ratings
56.25%
Success rate
1.33%
Average return
Main Sectors:
Stocks Rated by Amit Hazan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Upgrades: Buy | n/a | $193.50 | - | 3 | Dec 13, 2022 | |
| BVS Bioventus | Maintains: Neutral | $13 → $2.5 | $10.68 | -76.59% | 5 | Nov 30, 2022 | |
| SKIN The Beauty Health Company | Maintains: Buy | $22 → $19 | $1.67 | +1,037.72% | 4 | Nov 23, 2022 | |
| SHC Sotera Health Company | Maintains: Neutral | $9 → $8 | $13.71 | -41.65% | 4 | Nov 23, 2022 | |
| LIVN LivaNova | Maintains: Buy | $73 → $63 | $49.95 | +26.13% | 3 | Nov 23, 2022 | |
| BDX Becton, Dickinson and Company | Maintains: Buy | $319 → $272 | $247.60 | +9.85% | 8 | Nov 23, 2022 | |
| BLCO Bausch + Lomb | Maintains: Neutral | $19 → $17 | $17.35 | -2.02% | 3 | Nov 23, 2022 | |
| OM Outset Medical | Maintains: Buy | $34 → $29 | $0.80 | +3,525.00% | 2 | Nov 9, 2022 | |
| PRCT PROCEPT BioRobotics | Maintains: Neutral | $39 → $44 | $72.50 | -39.31% | 2 | Nov 4, 2022 | |
| EW Edwards Lifesciences | Maintains: Neutral | $97 → $73 | $72.45 | +0.76% | 3 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $60 → $53 | $32.56 | +62.78% | 11 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $57 | $46.98 | +21.33% | 1 | Oct 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $11 → $9.5 | $11.79 | -19.42% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $111 → $104 | $127.93 | -18.71% | 7 | Jul 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $60 | $15.00 | +300.00% | 3 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $129 → $115 | $90.82 | +26.62% | 9 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $248 → $150 | $391.29 | -61.67% | 2 | Apr 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $46 | $102.36 | -55.06% | 1 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $242 | $571.88 | -57.74% | 8 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $177 | $109.48 | +61.67% | 5 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $139 → $147 | $152.15 | -3.38% | 6 | Feb 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $3.5 → $3.9 | $2.23 | +74.89% | 3 | Nov 1, 2018 |
Inspire Medical Systems
Dec 13, 2022
Upgrades: Buy
Price Target: n/a
Current: $193.50
Upside: -
Bioventus
Nov 30, 2022
Maintains: Neutral
Price Target: $13 → $2.5
Current: $10.68
Upside: -76.59%
The Beauty Health Company
Nov 23, 2022
Maintains: Buy
Price Target: $22 → $19
Current: $1.67
Upside: +1,037.72%
Sotera Health Company
Nov 23, 2022
Maintains: Neutral
Price Target: $9 → $8
Current: $13.71
Upside: -41.65%
LivaNova
Nov 23, 2022
Maintains: Buy
Price Target: $73 → $63
Current: $49.95
Upside: +26.13%
Becton, Dickinson and Company
Nov 23, 2022
Maintains: Buy
Price Target: $319 → $272
Current: $247.60
Upside: +9.85%
Bausch + Lomb
Nov 23, 2022
Maintains: Neutral
Price Target: $19 → $17
Current: $17.35
Upside: -2.02%
Outset Medical
Nov 9, 2022
Maintains: Buy
Price Target: $34 → $29
Current: $0.80
Upside: +3,525.00%
PROCEPT BioRobotics
Nov 4, 2022
Maintains: Neutral
Price Target: $39 → $44
Current: $72.50
Upside: -39.31%
Edwards Lifesciences
Nov 3, 2022
Maintains: Neutral
Price Target: $97 → $73
Current: $72.45
Upside: +0.76%
Nov 3, 2022
Maintains: Sell
Price Target: $60 → $53
Current: $32.56
Upside: +62.78%
Oct 11, 2022
Initiates: Buy
Price Target: $57
Current: $46.98
Upside: +21.33%
Aug 8, 2022
Maintains: Neutral
Price Target: $11 → $9.5
Current: $11.79
Upside: -19.42%
Jul 25, 2022
Maintains: Sell
Price Target: $111 → $104
Current: $127.93
Upside: -18.71%
Jul 14, 2022
Maintains: Neutral
Price Target: $80 → $60
Current: $15.00
Upside: +300.00%
Jan 18, 2022
Maintains: Neutral
Price Target: $129 → $115
Current: $90.82
Upside: +26.62%
Apr 1, 2020
Downgrades: Sell
Price Target: $248 → $150
Current: $391.29
Upside: -61.67%
Feb 13, 2020
Initiates: Neutral
Price Target: $46
Current: $102.36
Upside: -55.06%
Feb 13, 2020
Initiates: Buy
Price Target: $242
Current: $571.88
Upside: -57.74%
Feb 13, 2020
Initiates: Buy
Price Target: $177
Current: $109.48
Upside: +61.67%
Feb 25, 2019
Maintains: Neutral
Price Target: $139 → $147
Current: $152.15
Upside: -3.38%
Nov 1, 2018
Upgrades: Neutral
Price Target: $3.5 → $3.9
Current: $2.23
Upside: +74.89%